BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price traded up 3.9% during trading on Thursday . The company traded as high as $1.88 and last traded at $1.85. 50,428 shares traded hands during mid-day trading, a decline of 100% from the average session volume of 62,169,492 shares. The stock had previously closed at $1.78.
BioRestorative Therapies Stock Performance
The stock has a market cap of $2.79 billion, a price-to-earnings ratio of -1.59 and a beta of 102.36. The company has a 50-day moving average of $1.94 and a 200-day moving average of $1.73.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- High Flyers: 3 Natural Gas Stocks for March 2022
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Comparing and Trading High PE Ratio Stocks
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- How to Plot Fibonacci Price Inflection Levels
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
